Patent ID: 7790746

Claim:
A compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein G 1 , G 2 , G 3 , and G 4 are each C; G 5 and G 6 are each CH; and G 7 and G 8 are each CR 2 ; D 1 and D 2 are each independently CH, CR 3 , N, or (NR 3 ) + ; R 6 , R 7 , R 8 , and R 9 are each independently H, halogen, CF 3 , OCF 3 , CN, CONHR 4 , CONR 4 R 5 , SO 2 Me, SO 2 NHR 4 , SO 2 NR 4 R 5 , NHCOR 4 , NHR 4 , NR 4 R 5 , OR 4 , NO 2 , or CH 2 R 4 ; R 4 and R 5 are each independently H, C 1 -C 6 alkyl or cycloalkyl optionally substituted with amino, hydroxy, methoxy, —CN, —COOH, or —SO 2 NH 2 groups, or with one or more oxygen, sulfur or nitrogen atoms as part of the cycloalkyl structure; R 2 and R 3 are each independently H, NHR 4 , NR 4 R 5 , OR 4 , NO 2 or CH 2 R 4 , wherein R 4 and R 5 are defined as above; X is H or C 1 -C 6 alkyl optionally substituted with amino, hydroxy or methoxy groups, or with one or more oxygen or nitrogen atoms as part of a cycloalkyl structure; Y is CONR 4 or NR 4 CO, wherein R 4 is as defined as above; o, m and p represent positions of attachment of the moiety Z; Z is one of the groups Q2, Q4, Q5, Q6, Q7, Q8, Q10, Q37, Q38, Q39, Q40, Q41, Q42 or Q43 represented in formula (II): wherein A is S(O) w and w is 0, 1 or 2; G 9 , G 10 , G 11 , G 12 and G 13 are each independently C, N, (NR 10 ) + , (NR 11 ) + , (NR 12 ) + or (NR 13 ) + ; but at least three of G 9 , G 10 , G 11 , G 12 and G 13 are independently C; and R 10 , R 11 , R 12 , R 13 , and R 14 are each independently H, halogen, alkyl, CF 3 , OCF 3 , CN, CONHR 4 , CONR 4 R 5 , SO 2 Me, SO 2 NHR 4 , SO 2 NR 4 R 5 , NHCOR 4 , NHR 4 , NR 4 R 5 , OR 4 , NO 2 or CH 2 R 4 , wherein R 4 and R 5 are as defined above.